Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

Clinical trial NCT07225270 · RECRUITING

Trial details

NCT number: NCT07225270
Sponsor: Genmab
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Cancer Platinum-sensitive Ovarian Cancer PSOC

Start date: 2026-04-03
Primary completion: 2028-10-01
Enrollment: 544

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.